株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

分子細胞遺伝学市場:世界の産業分析・規模・シェア・成長・動向・予測

Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 279146
出版日 ページ情報 英文 96 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
分子細胞遺伝学市場:世界の産業分析・規模・シェア・成長・動向・予測 Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2013年08月21日 ページ情報: 英文 96 Pages
概要

分子細胞遺伝学の分野は、蛍光 in situ ハイブリダイゼーション(FISH)およびアレイ比較ゲノムハイブリダイゼーション(aCGH)技術の需要拡大によって、大幅に成長しています。

当レポートでは、世界の分子細胞遺伝学市場について、技術、アプリケーションおよび地域別に分析し、各セグメントにおける市場規模と予測、市場成長の促進因子と阻害因子、将来の機会、競合情勢および主要企業のプロファイルを提供しており、概略下記内容でお届け致します。

第1章 序文

第2章 エグゼクティブサマリー

第3章 世界のゲノミクス・プロテオミクス市場概要

  • ゲノミクス・プロテオミクス産業の概要・画期的な出来事
  • ゲノミクス・プロテオミクス技術のアプリケーション
    • 農業・畜産
    • 創薬
    • フォレンジック
    • プロテオゲノミクス調査
    • 疾病特定・診断・管理
  • 市場成長促進因子
    • 促進因子
    • 阻害因子
    • 市場機会
  • 市場魅力分析:地域別
  • ポーターのファイブフォース分析

第4章 世界のゲノミクス・プロテオミクス試薬・調査キット市場

  • サンプル調製キット市場
    • 世界のサンプル調製キット市場:セグメント別
    • ポリメラーゼ連鎖反応(PCR)向けパッケージドサンプル調製
    • 質量分析向けパッケージドサンプル調製
    • クロマトグラフィー向けパッケージドサンプル調製
    • 電気泳動向けパッケージドサンプル調製
  • 精製試薬キット
    • 世界の精製試薬キット市場:セグメント別
    • 世界の精製キット市場:地域別
  • 電気泳動キット
    • 世界の電気泳動キット市場:地域別
    • キャピラリー電気泳動
    • ゲル電気泳動
  • バイオチップ・マイクロアレイ
    • 世界のバイオチップ・マイクロアレイ市場:地域別
    • DNAマイクロアレイ
    • タンパク質・ペプチドマイクロアレイ

第5章 世界のゲノミクス・プロテオミクス分析ツール市場:技術別

  • クロマトグラフィー
    • 世界のクロマトグラフィー市場:種類別
    • 世界のクロマトグラフィー市場:地域別
    • ガスクロマトグラフィー
    • 液体クロマトグラフィー
  • 質量分析器
    • 世界の質量分析器市場:アナライザー別
    • タンデム質量分析計
    • 四重極質量分析計(QMS)
    • フーリエ変換型質量分析計(FTMS)
    • TOF質量分析計
    • その他の質量分析計
  • サーマルサイクラー
  • 次世代シーケンシング

第6章 ゲノミクス・プロテオミクス市場:地域別

  • イントロダクション
  • 北米
    • セグメント別
  • 欧州
    • セグメント別
  • アジア太平洋地域
    • セグメント別
  • その他
    • セグメント別

第7章 主要企業の市場シェア分析

第8章 企業プロファイル

  • Affymetrix
    • 財務概要
    • 製品ポートフォリオ
    • ビジネス戦略
    • 近年の発展動向
  • Agilent Technologies
  • Becton Dickinson & Company
  • Bio-Rad
  • Bruker Corporation
  • Danaher Corporation
  • Illumina, Inc.
  • Life Technologies Corporation
  • Merck Millipore
  • Myriad Genetics, Inc.
  • Perkinelmer
  • Qiagen
  • Shimadzu Biotech (島津製作所)
  • Sigma Aldrich Corporation
  • Thermo Fisher Scientific

図表リスト

目次

Molecular cytogenetics field is witnessing a significant growth owing to the growing demand of FISH and aCGH techniques. The advent of FISH has managed to overcome the loopholes of conventional cytogenetics techniques; FISH enables the detection of both structural and numerical chromosomal rearrangements. The technique has been used significantly over the past few years for the detection of copy number variations and assessment of specific nucleic acids.

The research report on the molecular cytogenetics market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these technologies. The overall molecular cytogenetics market is categorized on the basis of technology in two major categories, namely, Fluorescent In-situ hybridization (FISH) and array based comparative genomic hybridization (aCGH). The market is also categorized on the basis of applications in which major areas such as genetic disorders, cancer, personalized medicine and others are covered. The market for all these segments is estimated for the period 2011 - 2019 in terms of value (USD Million).

The market has also been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the molecular cytogenetics market and future opportunities are provided in the report.

Competitive landscape and end user analysis for the product types is highlighted and the market players are profiled with attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2012 are provided, and recommendations to accentuate market shares and ensure sustainability are also put forward in this report. Key market player profiles in this report include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Life Technologies Corporation, Leica Biosystems, Illumina, inc., Oxford Gene Technology and others.

The global molecular cytogenetics market is segmented into the following categories:

Molecular Cytogenetics Market, by Technology

  • FISH
  • aCGH

Molecular Cytogenetics Market, by Applications

  • Cancer
  • Personalized Medicines
  • Genetic Disorders
  • Others

Molecular Cytogenetics Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019)
  • 2.2. Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million)
  • 2.3. Global Molecular Cytogenetics Market, by Application, 2012 (USD Million)

Chapter 3 - Market Overview

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Introduction of advanced technologies
    • 3.2.2. Rising incidence of cancer cases
  • 3.3. Market Restraints
    • 3.3.1. Issues with medical reimbursement
  • 3.4. Market Opportunities
    • 3.4.1. Advent of Next Generation Sequencing
    • 3.4.2. Tapping the emerging economies
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining power of buyers
    • 3.5.2. Bargaining power of suppliers
    • 3.5.3. Threat of new entrants
    • 3.5.4. Threat of substitutes
    • 3.5.5. Competitive rivalry
  • 3.6. Market Attractiveness Analysis
  • 3.7. Market Share Analysis, by Key Players (%)
    • 3.7.1. Global Molecular Cytogenetics Market Share Analysis, by Key Players (%)
  • 3.8. End User Analysis
    • 3.8.1. Global Molecular Cytogenetics End User Analysis

Chapter 4 - Molecular Cytogenetics Market, by Technology

  • 4.1. Overview
    • 4.1.1. Global Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • 4.2. Fluorescence in situ hybridization (FISH)
    • 4.2.1. Global FISH Market, 2011 - 2019 (USD Million)
  • 4.3. Array-Comparative Genomic Hybridization (aCGH)
    • 4.3.1. Global aCGH Market, 2011 - 2019 (USD Million)

Chapter 5 - Molecular Cytogenetics Market, by Applications

  • 5.1. Overview
    • 5.1.1. Global Molecular Cytogenetics Market, by Application, 2011 - 2019 (USD Million)
  • 5.2. Cancer
    • 5.2.1.1. Global Cancer Application Market, 2011 - 2019 (USD Million)
  • 5.3. Personalized Medicines
    • 5.3.1.1. Global Personalized Medicine Application Market, 2011 - 2019 (USD Million)
  • 5.4. Genetic Disorders
    • 5.4.1.1. Global Genetic Disorder Application Market, 2011 - 2019 (USD Million)
  • 5.5. Others (Neurological, Cardiovascular and Infectious Diseases)
    • 5.5.1.1. Global Others Application Market, 2011 - 2019 (USD Million)

Chapter 6 - Molecular Cytogenetics Market, by Geography

  • 6.1. Overview
    • 6.1.1. Global Molecular Cytogenetics Market, by Geography, 2011 - 2019 (USD Million)
  • 6.2. Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %)
  • 6.3. North America
    • 6.3.1. North America Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
    • 6.3.2. North America Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
    • 6.4.2. Europe Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • 6.5. Asia-Pacific
    • 6.5.1. Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
    • 6.5.2. Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • 6.6. RoW
    • 6.6.1. RoW Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
    • 6.6.2. RoW Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Investment in emerging economies
  • 7.2. Mergers and Acquisitions

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Affymetrix, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. Agilent Technologies, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Applied Spectral Imaging, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
  • 8.5. BI Biological Industries
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategy
  • 8.6. Bio-Rad Laboratories
    • 8.6.1. Company overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. CytoTest Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategy
  • 8.8. Cytognomix, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Recent Developments
  • 8.9. F. Hoffmann-La Roche Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategy
    • 8.9.5. Recent Developments
  • 8.10. Illumina Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. LEICA BIOSYSTEMS
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategy
    • 8.11.5. Recent Development
  • 8.12. Life Technologies Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategy
    • 8.12.5. Recent Developments
  • 8.13. Oxford Gene Technology
    • 8.13.1. Company Overview
    • 8.13.2. Financial Overview
    • 8.13.3. Product Portfolio
    • 8.13.4. Business Strategy
    • 8.13.5. Recent Developments
  • 8.14. PerkinElmer, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Financial Overview
    • 8.14.3. Product Portfolio
    • 8.14.4. Business Strategy
    • 8.14.5. Recent Developments
  • 8.15. SciGene Corporation
    • 8.15.1. Company Overview
    • 8.15.2. Financial Overview
    • 8.15.3. Product Portfolio

List of Figures

  • FIG. 1: Molecular Cytogenetics: Market Segmentation
  • FIG. 2: Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million)
  • FIG. 3: Global Molecular Cytogenetics Market, by Applications, 2012 (USD Million)
  • FIG. 4: Porter's Five Forces Analysis: Global Molecular Cytogenetics Market
  • FIG. 5: Market Attractiveness Analysis: Global Molecular Cytogenetics Market, by Geography
  • FIG. 6: Molecular Cytogenetics: Market Share, by Key Players, 2012 (%)
  • FIG. 7: Molecular Cytogenetics: End User Analysis, 2012
  • FIG. 8: FISH Procedural Steps
  • FIG. 9: Global FISH Market, 2011 - 2019 (USD Million)
  • FIG. 10: Global aCGH Market, 2011 - 2019 (USD Million)
  • FIG. 11: Global Cancer Application Market, 2011 - 2019 (USD Million)
  • FIG. 12: Global Personalized Medicine Application Market, 2011 - 2019 (USD Million)
  • FIG. 13: Global Genetic Disorders Application Market, 2011 - 2019 (USD Million)
  • FIG. 14: Global Others Applications Market, 2011 - 2019 (USD Million)
  • FIG. 15: Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 16: Abbott Laboratories, Annual Revenues: 2010 - 2012 (USD Billion)
  • FIG. 17: Affymetrix, Inc. Annual Revenues: 2010 - 2012 (USD Million)
  • FIG. 18: Agilent Technologies, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 19: Bio-Rad Laboratories, Annual Revenues: 2010 - 2012 (1 Euro = 1.32 USD) (USD Million)
  • FIG. 20: F. Hoffmann-La Roche Ltd., Annual Revenues: 2010 - 2012 (1 Swiss Franc = 1.09 USD) (USD Billion)
  • FIG. 21: Illumina Inc., Annual Revenues: 2010-2012 (USD Million)
  • FIG. 22: Life Technologies Corporation, Annual Revenues: 2010 - 2012 (USD Million)
  • FIG. 23: PerkinElmer Inc., Annual Revenues: 2010 - 2012 (USD Billion)

List of Tables

  • TABLE 1: Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019)
  • TABLE 2: Global Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 3: Global Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • TABLE 4: Global Molecular Cytogenetics Market, by Geography, 2011 - 2019 (USD Million)
  • TABLE 5: North America Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 6: North America Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • TABLE 7: Europe Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 8: Europe Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • TABLE 9: Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 10: Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
  • TABLE 11: RoW Molecular Cytogenetics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 12: RoW Molecular Cytogenetics Market, by Applications, 2011 - 2019 (USD Million)
Back to Top